# Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

> **NCT01139164** · PHASE2 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 78 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DRUG:** Regimen A
- **DRUG:** Regimen B
- **DRUG:** Regimen C

## Key facts

- **NCT ID:** NCT01139164
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2014-09
- **Final completion:** 2015-12
- **Target enrollment:** 78 (ACTUAL)
- **Why stopped:** Study halted prematurely due to low accrual.
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01139164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01139164, "Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01139164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*